Low-dose sirolimus in combination with mycophenolate in calcineurin inhibitor elimination: The Kuwaiti experience

被引：2

作者：

Johny, KV ^{[1
]}

Nampoory, MRN ^{[1
]}

Hamid, MH ^{[1
]}

Samhan, NM ^{[1
]}

Al-Moussawi, M ^{[1
]}

机构：

[1] Kuwait Univ, Fac Med, Dept Med, Hamad El Essa Organ Transplant Ctr, Safat 13110, Kuwait

来源：

TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 07期

关键词：

D O I：

10.1016/j.transproceed.2003.09.033

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2750 / 2751

页数：2

共 7 条

[1] Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine [J].

Groth, CG ;

Bäckman, L ;

Morales, JM ;

Calne, R ;

Kreis, H ;

Lang, P ;

Touraine, JL ;

Claesson, K ;

Campistol, JM ;

Durand, D ;

Wramner, L ;

Brattström, C ;

Charpentier, B .

TRANSPLANTATION, 1999, 67 (07) :1036-1042

[2] Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. [J].

Johnson, RWG ;

Kreis, H ;

Oberbauer, R ;

Brattström, C ;

Claesson, K ;

Eris, J .

TRANSPLANTATION, 2001, 72 (05) :777-786

[3] Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation [J].

Kahan, BD ;

Podbielski, J ;

Napoli, KL ;

Katz, SM ;

Meier-Kriesche, HU ;

Van Buren, CT .

TRANSPLANTATION, 1998, 66 (08) :1040-1046

[4] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients [J].

Kreis, H ;

Cisterne, JM ;

Land, W ;

Wramner, L ;

Squifflet, JP ;

Abramowicz, D ;

Campistol, JM ;

Morales, JM ;

Grinyo, JM ;

Mourad, G ;

Berthoux, FC ;

Brattström, C ;

Lebranchu, Y ;

Vialtel, P .

TRANSPLANTATION, 2000, 69 (07) :1252-1260

[5] A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts [J].

MacDonald, AS .

TRANSPLANTATION, 2001, 71 (02) :271-280

[6] Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation [J].

Morelon, E ;

Mamzer-Bruneel, MF ;

Peraldi, MN ;

Kreis, H .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) :18-20

[7] Sirolimus improves the two-year outcome of renal allografts in African-American patients [J].

Podder, H ;

Podbielski, J ;

Hussein, I ;

Katz, S ;

Van Buren, C ;

Kahan, BD .

TRANSPLANT INTERNATIONAL, 2001, 14 (03) :135-142

← 1 →